Literature DB >> 12148307

[Retropupillary fixation of the iris claw lens in aphakia. 1 year outcome of a new implantation techniques].

A Mohr1, F Hengerer, C Eckardt.   

Abstract

INTRODUCTION: There are several surgical options available for the correction of aphakia. We investigated if retropupillary fixation of an iris claw lens is a method combining the advantages of posterior chamber implants with a new low-risk method of intervention. PATIENTS AND METHODS: An iris claw lens was implanted in 48 eyes in the plano-convex direction (model 205 Y). For the calculation of the IOL power we estimated an A-constant of 116.8. The lens was pushed via a 5-mm wide corneal incision vertically in the anterior chamber and was fixed in the retropupillary position after turning in the horizontal direction. After aspiration of the viscoelastica the corneal incision was closed by a 10-0 nylon suture.
RESULTS: The implantation was successful in all patients. A visual improvement was noted in 27 patients (56.2%), an unchanged visual acuity was seen in 18 patients (37.5%) while 3 patients (6.2%) showed a loss of visual acuity. A cystoid macular edema was found by fluorescein angiography in two cases. Leakages in the area of the enclavation were not seen.
SUMMARY: The retropupillary fixation of an iris claw lens seems to have the advantages of a true posterior chamber implantation with a low intra- and postoperative risk profile. The easy implantation process with this technique could replace the normally applied sclera suture fixed implantation of a posterior chamber lens as the method of choice.

Entities:  

Mesh:

Year:  2002        PMID: 12148307     DOI: 10.1007/s00347-001-0563-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  32 in total

1.  [Progressive corneal opacity after autologous keratoplasty].

Authors:  V Witte; S Knappe; R Guthoff
Journal:  Ophthalmologe       Date:  2010-08       Impact factor: 1.059

2.  Position-dependent accommodative shift of retropupillary fixated iris-claw lenses.

Authors:  K Schöpfer; A Berger; C Korb; B M Stoffelns; N Pfeiffer; W Sekundo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-19       Impact factor: 3.117

Review 3.  [Intrascleral haptic fixation of intraocular lenses].

Authors:  G B Scharioth
Journal:  Ophthalmologe       Date:  2014-03       Impact factor: 1.059

4.  [A new posterior chamber intraocular lens for sutureless iris-fixated ciliary sulcus implantation in aphakic eyes without capsular support].

Authors:  P W Rieck; H Binder
Journal:  Ophthalmologe       Date:  2007-07       Impact factor: 1.059

5.  Primary iris claw IOL retrofixation with intravitreal triamcinolone acetonide in cases of inadequate capsular support.

Authors:  Aditya Kelkar; Rachana Shah; Viraj Vasavda; Jai Kelkar; Shreekant Kelkar
Journal:  Int Ophthalmol       Date:  2017-02-09       Impact factor: 2.031

Review 6.  [Blunt ocular trauma. Part I: blunt anterior segment trauma].

Authors:  A Viestenz; M Küchle
Journal:  Ophthalmologe       Date:  2004-12       Impact factor: 1.059

7.  Visual outcomes and complications following posterior iris-claw aphakic intraocular lens implantation combined with penetrating keratoplasty.

Authors:  Johannes Gonnermann; Necip Torun; Matthias K J Klamann; Anna-Karina B Maier; Christoph V Sonnleithner; Antonia M Joussen; Peter W Rieck; Eckart Bertelmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-19       Impact factor: 3.117

Review 8.  [Retropupillary iris claw intraocular lens implantation technique for aphakia].

Authors:  W Sekundo; T Bertelmann; S Schulze
Journal:  Ophthalmologe       Date:  2014-04       Impact factor: 1.059

9.  [Anterior chamber intraocular lenses for aphakia correction].

Authors:  T Kohnen; F H Hengerer
Journal:  Ophthalmologe       Date:  2014-04       Impact factor: 1.059

10.  Implantation of retropupillar iris claw lenses with and without combined penetrating keratoplasty.

Authors:  Florian Rüfer; Mark Saeger; Bernhard Nölle; Johann Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.